| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.804.541 | 4.921.786 | 5.608.958 | 6.313.364 | 7.934.996 | 8.029.304 | 8.334.727 | 9.557.156 | 9.822.532 | 11.427.057 |
| Total Income - EUR | 5.045.138 | 5.348.130 | 5.853.842 | 6.479.433 | 7.977.601 | 8.246.946 | 8.817.315 | 9.993.882 | 10.053.832 | 12.095.519 |
| Total Expenses - EUR | 4.143.443 | 4.991.602 | 5.232.280 | 5.251.876 | 6.109.171 | 6.371.457 | 6.751.067 | 8.304.699 | 8.819.802 | 10.116.965 |
| Gross Profit/Loss - EUR | 901.695 | 356.528 | 621.562 | 1.227.556 | 1.868.430 | 1.875.489 | 2.066.248 | 1.689.183 | 1.234.030 | 1.978.554 |
| Net Profit/Loss - EUR | 803.548 | 329.631 | 497.346 | 1.201.069 | 1.655.578 | 1.579.542 | 1.760.727 | 1.442.823 | 1.078.773 | 1.717.310 |
| Employees | 116 | 134 | 0 | 142 | 153 | 165 | 143 | 151 | 173 | 141 |
Check the financial reports for the company - Slavia Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.295.530 | 2.263.924 | 2.020.550 | 3.205.962 | 3.742.952 | 4.538.824 | 4.540.086 | 4.239.268 | 4.549.472 | 4.956.796 |
| Current Assets | 2.672.806 | 2.516.943 | 3.722.085 | 3.178.068 | 3.962.791 | 4.935.610 | 5.105.586 | 6.628.103 | 8.564.193 | 10.573.395 |
| Inventories | 854.369 | 1.056.291 | 1.719.882 | 1.254.747 | 1.038.694 | 1.897.302 | 1.901.066 | 2.134.035 | 2.330.309 | 1.761.074 |
| Receivables | 1.730.455 | 1.278.148 | 1.646.473 | 1.752.303 | 2.685.107 | 2.847.768 | 2.656.031 | 3.910.311 | 5.078.623 | 3.929.374 |
| Cash | 87.982 | 182.503 | 355.730 | 171.018 | 238.991 | 190.539 | 548.489 | 583.756 | 1.155.261 | 4.882.948 |
| Shareholders Funds | 2.240.183 | 2.500.088 | 2.955.128 | 4.026.695 | 5.203.307 | 6.400.236 | 7.731.169 | 8.422.149 | 9.468.504 | 10.529.797 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 2.710.945 | 2.280.778 | 2.787.507 | 2.357.334 | 2.502.436 | 3.074.198 | 1.914.503 | 2.158.392 | 2.983.341 | 3.822.950 |
| Income in Advance | 17.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2120 - 2120" | |||||||||
| CAEN Financial Year |
2120
|
|||||||||
Comments - Slavia Pharm Srl